Several studies have probed the contributions of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase to NADPH production and have identified these enzymes as therapeutic targets for cancer, including glioblastoma (13, 16, 19, 20). This evidence concerns the gene G6PD and glioblastoma.